Morris Gabriel S
SEC CIK 1889967 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMMX | Immix Biopharma, Inc. | CFO, Dir | 291.4K | $51.5K | — | 13 | 2021-12-20 | 2025-12-10 |
Most active insiders at IMMX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Morris Gabriel S | CFO, Dir | $5,067 | — |
| 2 | Rachman Ilya M | CEO, COB, Dir | $4,976 | — |
| 3 | Chudnovsky Yekaterina | Dir | — | — |
| 4 | Hsu Jason | Dir | — | — |
| 5 | Ng Carey | Dir | — | — |
| 6 | Marquet Magda | Dir | — | — |
| 7 | Adams Helen C. | Dir | — | — |
| 8 | BUCHAN JANE | Dir | — | — |
| 9 | CHANG NANCY T | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-10 | 2025-12-10 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $6.58 | +770 | 291.4K | +0.3% | +$5,067 |
| DI | 2025-12-10 | 2025-12-08 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | X - OptEx | $0.8 | +156.0K | 426.8K | +58% | +$124.8K |
| 2025-09-17 | 2025-09-16 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $1.97 | +2,600 | 290.7K | +0.9% | +$5,122 | |
| 2025-06-20 | 2025-06-18 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $2.28 | +2,225 | 288.1K | +0.8% | +$5,073 | |
| 2024-06-10 | 2024-06-07 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $2.12 | +2,500 | 285.8K | +0.9% | +$5,300 | |
| 2024-06-05 | 2024-06-04 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $1.81 | +3,300 | 283.3K | +1% | +$5,973 | |
| MI | 2024-05-20 | 2024-05-20 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | A - Grant | — | +48.3K | 270.8K | +22% | — |
| 2024-05-20 | 2024-05-20 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | A - Grant | — | +194.2K | 280.0K | +226% | — | |
| 2024-05-14 | 2024-05-14 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $2.23 | +4,500 | 85.8K | +6% | +$10.0K | |
| 2022-11-15 | 2022-11-14 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $0.94 | +5,200 | 81.3K | +7% | +$4,888 | |
| D | 2021-12-20 | 2021-12-20 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | C - Cnv Deriv | $0.85 | +74.1K | 74.1K | New | +$63.0K |
| DMI | 2021-12-20 | 2021-12-20 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | C - Cnv Deriv | $0.85 | +246.7K | 246.7K | New | +$209.7K |
| D | 2021-12-20 | 2021-12-20 | IMMX | Immix Biopharma, Inc. | Morris Gabriel S | CFO, Dir | P - Purchase | $5.00 | +2,000 | 76.1K | +3% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations